2025 NAPSRX
CNPR
QUESTIONS WITH DETAILED VERIFIED
ANSWERS
(REVISED 18TH EDITION) 2025–2026
1. what does a STAT order mean? - CORRECT ANSWER >> -a drug needed
immediately and given only once
2. what information does the overdosage section of the labeling provide? -
CORRECT ANSWER >> -signs, symptoms and treatment of acute overdoses
3. types of drug-drug interactions: - CORRECT ANSWER >> -duplication,
opposition (antagonism) and alteration (p.51)
4. tolerance vs resistance - CORRECT ANSWER >> -tolerance is the
diminished response to a drug; resistance is the cells ability to resist the
effects of the drug on them.
https://www.stuvia.com/user/successguarantee
, 5. abbreviated new drug application (ANDA) - CORRECT ANSWER >> -the
process by which applicants must scientifically demonstrate to the FDA that
their generic product is bioequivalent to or performs in the same way as the
innovator drug, no duplicate testing (p. 75)
6. the Hatch-Waxman Act of 1984 - CORRECT ANSWER >> --A.K.A. Drug Price
Competition and Patent Restoration Act
-made it easier to bring generic drugs to the market by requiring the FDA to only
look at bioavailability studies in order to approve an ANDA.
-gave protection to the research based manufacturers by providing a 30-month
automatic cooling off period once an ANDA is challenged for patent infringement
(p. 75)
https://www.stuvia.com/user/successguarantee
CNPR
QUESTIONS WITH DETAILED VERIFIED
ANSWERS
(REVISED 18TH EDITION) 2025–2026
1. what does a STAT order mean? - CORRECT ANSWER >> -a drug needed
immediately and given only once
2. what information does the overdosage section of the labeling provide? -
CORRECT ANSWER >> -signs, symptoms and treatment of acute overdoses
3. types of drug-drug interactions: - CORRECT ANSWER >> -duplication,
opposition (antagonism) and alteration (p.51)
4. tolerance vs resistance - CORRECT ANSWER >> -tolerance is the
diminished response to a drug; resistance is the cells ability to resist the
effects of the drug on them.
https://www.stuvia.com/user/successguarantee
, 5. abbreviated new drug application (ANDA) - CORRECT ANSWER >> -the
process by which applicants must scientifically demonstrate to the FDA that
their generic product is bioequivalent to or performs in the same way as the
innovator drug, no duplicate testing (p. 75)
6. the Hatch-Waxman Act of 1984 - CORRECT ANSWER >> --A.K.A. Drug Price
Competition and Patent Restoration Act
-made it easier to bring generic drugs to the market by requiring the FDA to only
look at bioavailability studies in order to approve an ANDA.
-gave protection to the research based manufacturers by providing a 30-month
automatic cooling off period once an ANDA is challenged for patent infringement
(p. 75)
https://www.stuvia.com/user/successguarantee
